Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins
Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
